These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8999121)

  • 41. [Preparation and performance of pravastatin sodium-loaded chitosan microspheres].
    Feng J; Liu Z; Yan Y; Hu M; Lu L; You W
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jun; 35(6):879-82. PubMed ID: 26111689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aqueous preparation and evaluation of albumin-chitosan microspheres containing indomethacin.
    Bayomi MA
    Drug Dev Ind Pharm; 2004 Apr; 30(4):329-39. PubMed ID: 15132175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and characterization of chitosan microspheres containing doxifluridine.
    Yoshino T; Machida Y; Onishi H; Nagai T
    Drug Dev Ind Pharm; 2003 Apr; 29(4):417-27. PubMed ID: 12737535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclophosphamide loaded albumin microspheres II. Release characteristics.
    Vural I; Kaş HS; Hincal AA; Cavé G
    J Microencapsul; 1990; 7(4):511-6. PubMed ID: 2125078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle.
    Jameela SR; Jayakrishnan A
    Biomaterials; 1995 Jul; 16(10):769-75. PubMed ID: 7492707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-linked chitosan microspheres for oral delivery of insulin: Taguchi design and in vivo testing.
    Jose S; Fangueiro JF; Smitha J; Cinu TA; Chacko AJ; Premaletha K; Souto EB
    Colloids Surf B Biointerfaces; 2012 Apr; 92():175-9. PubMed ID: 22221459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of cross-linked chitosan microparticles containing metronidazole for periodontitis treatment.
    Pichayakorn W; Boonme P
    Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1197-202. PubMed ID: 23827560
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin.
    Nishioka Y; Kyotani S; Okamura M; Miyazaki M; Okazaki K; Ohnishi S; Yamamoto Y; Ito K
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2871-3. PubMed ID: 2076575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and evaluation of chitosan microspheres containing bisphosphonates.
    Patashnik S; Rabinovich L; Golomb G
    J Drug Target; 1997; 4(6):371-80. PubMed ID: 9239577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and development of multiparticulate system for targeted drug delivery to colon.
    Chourasia MK; Jain SK
    Drug Deliv; 2004; 11(3):201-7. PubMed ID: 15204639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formulation factors in preparing BTM-chitosan microspheres by spray drying method.
    Huang Y; Yeh M; Chiang C
    Int J Pharm; 2002 Aug; 242(1-2):239-42. PubMed ID: 12176254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
    Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J
    Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro analysis of the release of incorporated agents from sodium caseinate microspheres.
    Heelan BA; Corrigan OI
    J Microencapsul; 1997; 14(1):63-78. PubMed ID: 8994076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 5-Fluorouracil monodispersed chitosan microspheres: Microfluidic chip fabrication with crosslinking, characterization, drug release and anticancer activity.
    He T; Wang W; Chen B; Wang J; Liang Q; Chen B
    Carbohydr Polym; 2020 May; 236():116094. PubMed ID: 32172896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microencapsulation of chlorpheniramine maleate-resin particles with crosslinked chitosan for sustained release.
    Huang RG; Schwartz JB; Ofner CM
    Pharm Dev Technol; 1999 Jan; 4(1):107-15. PubMed ID: 10027219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chitosan: properties, preparations and application to microparticulate systems.
    Kaş HS
    J Microencapsul; 1997; 14(6):689-711. PubMed ID: 9394251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats.
    Ganguly K; Kulkarni AR; Aminabhavi TM
    Drug Deliv; 2016 Oct; 23(8):2838-2851. PubMed ID: 26530807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation and characterization of Mitomycin-C loaded chitosan-coated alginate microspheres for chemoembolization.
    Misirli Y; Oztürk E; Kurşaklioğlu H; Denkbaş EB
    J Microencapsul; 2005 Mar; 22(2):167-78. PubMed ID: 16019902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation and characterization of 5-Fluorouracil loaded chitosan microspheres by a two-step solidification method.
    Sun Y; Gu L; Gao Y; Gao F
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):891-5. PubMed ID: 20606332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pH-sensitive nanocomposite microsphere based on chitosan and montmorillonite with in vitro reduction of the burst release effect.
    Hua S; Yang H; Wang A
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1106-14. PubMed ID: 20334540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.